Cox Russell J. 4
4 · Jazz Pharmaceuticals plc · Filed Dec 13, 2017
Insider Transaction Report
Form 4
Cox Russell J.
SVP, Sales and Marketing
Transactions
- Exercise/Conversion
Ordinary Shares
2017-12-11$8.23/sh+44,200$363,766→ 96,263 total - Exercise/Conversion
Ordinary Shares
2017-12-11$46.83/sh+4,867$227,922→ 101,130 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2017-12-11−44,200→ 0 totalExercise: $8.23Exp: 2020-08-24→ Ordinary Shares (44,200 underlying) - Exercise/Conversion
Ordinary Shares
2017-12-11$59.13/sh+1,691$99,989→ 102,821 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2017-12-11−4,867→ 0 totalExercise: $46.83Exp: 2022-08-08→ Ordinary Shares (4,867 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2017-12-11−1,691→ 0 totalExercise: $59.13Exp: 2023-03-04→ Ordinary Shares (1,691 underlying)
Footnotes (4)
- [F1]Includes 78 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2017.
- [F2]This incentive stock option is part of an option award granted on August 25, 2010. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of July 21, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of July 21, 2014.
- [F3]This incentive stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.
- [F4]This incentive stock option is part of an option award granted on March 5, 2013. The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017.